Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics免疫原性与药物暴露的关联及靶点结合在ADA发展中的重要性:一项抗SARS-CoV-2生物制剂的临床病例研究The AAPS JournalIF02025-10-230OA
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionSCIENCE TRANSLATIONAL MEDICINEIF14.62024-11-060PRE
Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory ApprovalCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-07-154PRE
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical DevelopmentCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-01-1016OAAI
Role of Vitamins A and D in BCR-ABL Arf-/- Acute Lymphoblastic LeukemiaSCIENTIFIC REPORTSIF3.92020-02-1110OAAI
Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosisJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-05-2349PREAI
Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase BJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-10-1861PREAI
In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-06-0170OAAI
Effect of repeated dosing on rifampin exposure in BALB/c miceEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72013-04-0116PREAI
Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-06-0125OAAI